France: CJEU issues decision on reconditioning by parallel importers

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

France: CJEU issues decision on reconditioning by parallel importers

Sponsored by

beau-de-lomenie.png

Jurisprudence has had fixed rules for a long time on the reconditioning of pharmaceutical products by parallel importers, without the consent of the trade mark owner.

The reconditioning must not affect the original condition of the product. The presentation of the product must not harm the image of the brand and its proprietor. If there is new packaging, it must clearly indicate the person who carried out the reconditioning and the product. Finally, the importer must notify the trade mark owner of the future sale and provide him with, on request, a specimen of the reconditioning.

These conditions allow the trade mark owner to maintain some control over the distribution of his products by parallel importers.

New opportunities for the parallel market are now offered by a decision recently rendered by the Court of Justice of the European Union (CJEU) (decision of the CJEU, May 17 2018 C-642/06).

In this case, the parallel importer added a new label on the pharmaceuticals to permit their importation. The trade mark owner opposed this commercialisation insofar as the importer failed to inform him about this reimport and the new packaging adopted.

The Court noted that in all cases until then the reconditioning had required the opening of the original packaging. Here, the packaging had not been modified, nor the original presentation affected.

The Court made the following points:

(i) the importer had limited himself to affixing an additional label on an unprinted part of the packaging, which had not been opened;

(ii) this label was small and included only the name of the parallel importer, its address and telephone number, a barcode and a pharmacological number.

As a result, affixing such a label did not contravene the trade mark holder's rights, and the parallel importer was not obliged to inform the trade mark holder of his action.

marie.jpg

Aurélia Marie

Cabinet Beau de Loménie

158, rue de l’Université

F - 75340 Paris Cedex 07 France

Tel: +33 1 44 18 89 00

Fax: +33 1 44 18 04 23

contact@bdl-ip.com

www.bdl-ip.com

more from across site and SHARED ros bottom lb

More from across our site

Exclusive data and analysis reveal how firms can differentiate themselves when it comes to costs and value
The Berlin office will mark the firm’s fourth German base and tenth overall
As we build up to another busy year for the IP STARS rankings and Managing IP Awards, we give a rundown of some of the major IP firms and trends in the UK
Three firms have received at least 13 nominations, while a further three have 12 nominations each
Harish Daiya discusses the value of IP monetisation, the benefits of a carefully structured day, and how to fit several coffee meetings into the working week
Directors at the firm explain how the drafting tool works, and why they may need to strengthen their team post-launch
A diversity pledge for in-house IP lawyers and well-known trademark recognition for Taj were also among the top talking points this week
Counsel are expecting policies that are favourable to patent owners and say the fear factor over applying for patents may diminish
Douglas Carsten says he is keen to increase fee earner headcount in the firm’s San Diego office, which opened this week
The deal could mean that hundreds of licensees in the pool would have access to a broader range of VVC patents
Gift this article